LFTD Partners (LIFD)
OTHER OTC:LIFD
Want to see LIFD full AI Analyst Report?
LIFD Stock Chart & Stats
$0.30
$0.00(0.00%)
At close: 4:00 PM EST
$0.30
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.11 - $0.39
Previous CloseN/A
Volume30.00
Average Volume (3M)1.38K
Market Cap
$2.67M
Enterprise Value$2.34M
Total Cash (Recent Filing)$2.09M
Total Debt (Recent Filing)$1.76M
Price to Earnings (P/E)―
Beta0.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding14,822,678
10 Day Avg. Volume3,614
30 Day Avg. Volume1,380
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.22
Price to Sales (P/S)0.08
P/FCF Ratio<0.01
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue0.06
Enterprise Value/Gross Profit0.28
Enterprise Value/Ebitda-0.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance Sheet FlexibilityDebt-to-equity near 0.14 gives the company meaningful balance-sheet flexibility, lowering refinancing and interest burdens. That capacity supports sustaining operations, funding working capital or targeted R&D during a multi-month turnaround window without immediate external financing.
Positive Operating & Free Cash FlowPositive TTM operating and free cash flow provide internal funding for working capital and modest capex, reducing reliance on dilutive equity or new debt. Over a 2–6 month horizon this cash generation underpins operational continuity and preserves strategic optionality.
Industry: Specialty & Generic DrugsOperating in specialty and generic drug manufacturing exposes the company to structural, recurring demand for medicines and niche products. That market positioning supports more stable product lifecycles and recurring revenue potential useful for medium-term planning and product investment.
Bears Say
Deeply Negative ProfitabilityA net margin near -67% indicates severe unprofitability that erodes equity and limits reinvestment. Such deep losses constrain management’s ability to invest in growth or absorb shocks, raising the likelihood that structural cost or revenue changes are needed to restore sustainable profitability.
Multi-year Profitability DeteriorationThe shift from multi-year profits to escalating losses signals weakening operating leverage or rising structural costs. A persistent downtrend reduces runway for strategic initiatives and increases risk of capital actions (cost cuts, asset sales, dilution) required to restore financial health over months.
Volatile Cash Conversion / Earnings MismatchIntermittent negative operating/free cash flow and volatile conversion between earnings and cash increase forecasting difficulty and raise liquidity risk. This inconsistency undermines confidence in recurring cash generation and complicates medium-term budgeting and financing plans.
LFTD Partners News
LIFD FAQ
What was LFTD Partners’s price range in the past 12 months?
LFTD Partners lowest stock price was $0.11 and its highest was $0.39 in the past 12 months.
What is LFTD Partners’s market cap?
LFTD Partners’s market cap is $2.67M.
When is LFTD Partners’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were LFTD Partners’s earnings last quarter?
Currently, no data Available
Is LFTD Partners overvalued?
According to Wall Street analysts LFTD Partners’s price is currently Overvalued.
Does LFTD Partners pay dividends?
LFTD Partners does not currently pay dividends.
What is LFTD Partners’s EPS estimate?
LFTD Partners’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LFTD Partners have?
LFTD Partners has 14,822,678 shares outstanding.
What happened to LFTD Partners’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of LFTD Partners?
Currently, no hedge funds are holding shares in LIFD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LFTD Partners
LFTD Partners Inc., through its subsidiary, Lifted Made, manufactures and sells psychedelic products under its Silly Shruum brand and hemp-derived cannabinoid products under its Urb Finest Flowers brand. The company was formerly known as Acquired Sales Corp. and changed its name to LFTD Partners Inc. in September 2021. LFTD Partners Inc. was incorporated in 1986 and is headquartered in Jacksonville, Florida.